JG
BIO icon

Jain Global’s Bio-Rad Laboratories Class A BIO Stock Holding History

Jain Global’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15,064
Closed -$3.64M – 1048
2025
Q2 		$3.64M Buy
15,064
+5,270
+54% +$1.25M 0.03% 391
2025
Q1 		$2.39M Buy
+9,794
New +$2.95M 0.03% 332

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Jain Global's BIO Position: Q3 2025 in Review

Jain Global sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2025, closing a stake of 15,064 shares — an estimated $3.64M sold.

Jain Global first reported a position in BIO in Q1 2025 and held it in 2 quarters. The position peaked at $3.64M in Q2 2025. 397 funds tracked by Wall St. Rank hold BIO as of Q3 2025.

  • Jain Global reported no remaining Bio-Rad Laboratories Class A position as of Q3 2025 after selling out during the quarter.
  • Jain Global sold 15,064 Bio-Rad Laboratories Class A shares in Q3 2025, an estimated $3.64M.
  • Jain Global first reported a position in Bio-Rad Laboratories Class A in Q1 2025 and held it in 2 quarters.
  • Jain Global's Bio-Rad Laboratories Class A position peaked at $3.64M in Q2 2025.
  • 397 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2025.

Based on Jain Global's 13F filing for Q3 2025, filed 14 Nov 2025.